Form 8-K - Current report:
SEC Accession No. 0001656472-24-000078
Filing Date
2024-06-25
Accepted
2024-06-25 17:07:33
Documents
17
Period of Report
2024-06-20
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K cron-20240620.htm   iXBRL 8-K 41543
2 EX-10.1 exhibit101-arcreditagreeme.htm EX-10.1 741186
3 EX-10.2 exhibit102-3rdamendedandre.htm EX-10.2 382467
8 GRAPHIC image_0a.jpg GRAPHIC 97647
  Complete submission text file 0001656472-24-000078.txt   1619684

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cron-20240620.xsd EX-101.SCH 2177
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cron-20240620_def.xml EX-101.DEF 2890
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cron-20240620_lab.xml EX-101.LAB 23477
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cron-20240620_pre.xml EX-101.PRE 13632
21 EXTRACTED XBRL INSTANCE DOCUMENT cron-20240620_htm.xml XML 2996
Mailing Address 111 PETER STREET SUITE 300 TORONTO A6 M5V 2H1
Business Address 111 PETER STREET SUITE 300 TORONTO A6 M5V 2H1 (416) 504-0004
Cronos Group Inc. (Filer) CIK: 0001656472 (see all company filings)

EIN.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38403 | Film No.: 241069813
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)